Work for Xenetic Biosciences, Inc.?

Claim Your Profile

Xenetic Biosciences, Inc. Logo Image

Xenetic Biosciences, Inc.

Xenetic Biosciences, Inc. Banner Image

Most Recent Annual Report

Upgrade your company profile to unlock all of your annual report content on AnnualReports.com

2019 Annual Report and Form 10K

Xenetic Biosciences, Inc.

Xenetic Biosciences, Inc. has reached its limit for free report views.

Upgrade your company profile to unlock all of your annual report content on AnnualReports.com

Archived Annual Reports

About Xenetic Biosciences, Inc.

1-10 Employees
Based in Framingham, Massachusetts

Xenetic Biosciences, Inc. is a biopharmaceutical company focused on progressing XCARTâ„¢, a personalized CAR T platform technology engineered to target patient- and tumor-specific neoantigens. The Company is initially advancing cell-based therapeutics targeting the unique B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas. XCARTâ„¢ has the potential to fuel a robust pipeline of therapeutic assets targeting high-value oncology indications.

Ticker:
XBIO
Exchange:
NASDAQ (See More NASDAQ Companies)
Industry:
Biotechnology (See More Biotechnology Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol